Cancer, Fertility Issues
Conditions
Brief summary
This is a single-center retrospective study carried out with a phone call follow-up to investigate women's decision not to return for criopreserved ovocytes use after cancer treatment. The study database includes all women who underwent fertility preservation cycles at a third-level university-affiliated center from January 2001 to December 2017. Patients were asked a set of standardized questions whose purpose was to investigate their present health conditions, cancer treatment and any potential relapses, their family projects and sentimental status, any spontaneous conception, and why they had not yet returned for embryo transfer. All data were recorded anonymously in our dataset.
Detailed description
All women who underwent oocyte cryopreservation cycles for oncological purposes from January 2001 to December 2017 at Fertility Center of Humanitas Research Hospital, Rozzano (Milano), Italy, were contacted. The survey's purpose was to investigate their present health conditions, cancer treatment and any potential relapses, their family projects and sentimental status, any spontaneous conception, and why they had not yet returned for oocytes use.
Interventions
OTHERFollow up survey
phone call follow-up to investigate women's decision not to return for embryo transfer after cancer treatment.
Sponsors
Istituto Clinico Humanitas
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No
Inclusion criteria
The study database includes all women who underwent fertility preservation cycles at a third-level university-affiliated center
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| return rate | from January 2001 to December 2021 | return rate of cancer patients who underwent fertility preservation |
Countries
Italy
Outcome results
None listed